Antony Hawthorne

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background The Colitis Once Daily Asacol ® (CODA) study assessed the efficacy and safety of once daily (OD) dosing with Mesalazine (Asacol ® , 2.4g as 3 x 800mg tablets) versus one 800mg tablet three times daily (TDS) over a 12 month period for patients in remission with ulcerative colitis (UC). Emerging evidence suggests OD Mesalazine is as effective as(More)
  • 1